SEC Form 4 · accession 0001127602-19-006016
LABCORP HOLDINGS INC. · LH
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
David P King
Officer — President & CEO · Director
Period of report
Feb 12, 2019
Accepted (ET)
Feb 14, 2019 · 4:44 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000920148
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Feb 12, 2019 | M | 3,513 | — | A | 247,852 | D | |
| Common Stock | Feb 12, 2019 | F | 1,571 | $146.59 | D | 246,281 | D | |
| Common Stock | holding | — | — | — | 23,635 | I | By grantor retained annuity trust | |
| Common Stock | holding | — | — | — | 34,462 | I | By grantor retained annuity trust |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Restricted Stock UnitF4,F1,F3 | — | Feb 12, 2019 | M | 3,513 | D | — | — | Common Stock | 3,513 | 11,247 | D |
| Restricted Stock UnitF4,F1,F5 | — | Feb 12, 2019 | A | 12,710 | A | — | — | Common Stock | 12,710 | 23,957 | D |
| Non-qualified Stock OptionsF6,F7 | $146.59 | Feb 12, 2019 | A | 52,300 | A | Feb 12, 2020 | Feb 11, 2029 | Common Stock | 52,300 | 52,300 | D |
Explanation of responses
- F1Each Restricted Stock Unit represents the contingent right to receive one share of Laboratory Corporation of America Holdings Common Stock.
- F2Stock withholding to satisfy tax withholding obligations.
- F3The Restricted Stock Units that have vested were part of a grant that vests in three equal annual installments beginning on 2/12/19.
- F4This number reflects the aggregate number of Restricted Stock Units held by the reporting person.
- F5The Restricted Stock Units vest in three equal annual installments beginning on 2/12/2020.
- F6Employee stock option (right to buy) granted pursuant to the Laboratory Corporation of America Holdings 2016 Omnibus Incentive Plan.
- F7The option vests in three equal installments beginning on the date reflected in this column.